GL1X · GenesisL1 explorer

Research workbench

PICK1 PDZ domain in complex with the small molecule inhibitor BIO124.

Analyse PICK1 PDZ domain in complex with the small molecule inhibitor BIO124. in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6BJO
Type
protein
Length
171 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Prkca-binding protein
UniProt
Q9NRD5
Ligands
DUY
Pockets
3 · best druggability 0.41

Structure

x-ray diffraction · 2 distinct chains · 16% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APrkca-binding proteinprotein8616% helix, 43% strandQ9NRD5
BPrkca-binding proteinprotein8516% helix, 38% strandQ9NRD5

Ligands and binding sites

  • DUY · (2S)-({4-(4-bromophenyl)-1-[1-(tert-butoxycarbonyl)-L-prolyl]piperidine-4-carbonyl}amino)(cyclopentyl)acetic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1660.410.8014empty
2720.390.7812empty
3520.300.7613empty

Interfaces

1 interface between chains.

  • A–B · 460 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 6BJO · PICK1 PDZ domain in complex with the small molecule inhibitor BIO124. · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9NRD5 · AlphaFold monomer V2.0 prediction for prkca-binding protein (Q9NRD5) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.